Docetaxel and autonomic cardiovascular control in anthracycline treated breast cancer patients

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 2045-2048

  Ekholm, Eeva ^a   Rantanen, Virpi ^a   Bergman, Maria ^a   Vesalainen, Risto ^b   Antila, Kari ^a   Salminen, Eeva ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b SEINÄJOKI CENTRAL HOSPITAL   (Finland)

Author keywords

Autonomic nervous system; Chemotherapy; Docetaxel; Heart rate variability

Indexed keywords

ANTHRACYCLINE; DOCETAXEL; EPIRUBICIN; PACLITAXEL; TAXOID;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; BREAST CANCER; CARDIOTOXICITY; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; FEMALE; HEART RATE; HOMEOSTASIS; HUMAN; METASTASIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; VAGUS NERVE;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BAROREFLEX; BLOOD PRESSURE; BREAST NEOPLASMS; EPIRUBICIN; FEMALE; HEART CONDUCTION SYSTEM; HEART FUNCTION TESTS; HEART RATE; HUMANS; MIDDLE AGED; PACLITAXEL; POSTURE; TAXOIDS; VAGUS NERVE;

EID: 0033891874     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nabholtz JM and Crown J: Phase III studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens: preliminary results. Semin Oncol 25: 4-9, 1998.
2. Chan S: Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy. Oncology Huntingt 11: 19-24, 1997.
3. Hortobagyi G: An expanding role for docetaxel. Semin Oncol 6: 1-3, 1998.
4. Piccart MJ, Gore M and Ten Bokel Huinink W: Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer. J Natl Cancer Inst 87: 676-681, 1995.
5. Hilkens PHE, Verweij J and Stoter G et al: Peripheral neurotoxicity induced by docetaxel. Neurology 46: 104-108, 1996.
6. Low PA: Laboratory evaluation of autonomic failure. In: Clinical autonomic disorders: evaluation and management (Low PA, ed.), First ed, Boston, USA, Litte, Brown and Company, 1993, pp 169-96.
7. La Rovere MT, Bigger Jr JT and Marcus FI et al: Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 351: 478-484, 1998.
8. Barron HV and Lesh MD: Autonomic nervous system and sudden cardiac death. JACC 27: 1053-1060, 1994.
9. Tsuji H, Venditti FJ, Manders ESA et al: Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham heart study. Circulation 90: 878-883, 1994.
10. Tahvanainen K, Lansimies E and Tikkanen P et al: Microcomputer-based monitoring of cardiovascular functions in simulated microgravity. Adv Space Res 12: (1)227-(1)236, 1992.
11. Pickering TGA Sleight P: Quantitative index of baroreflex activity in normal and hypertensive subjects using Valsalva's manoeuvre. Br Heart J 31: 392, 1969.
12. Airaksinen KEJ, Hartikainen JEK and Niemela MJ et al: Valsalva manoeuvre in the assessment of baroreflex sensitivity in patients with coronary artery disease. Eur Heart J 14: 1519-1523, 1993.
13. Hirsch JA and Bishop B: Respiratory sinus arrhythmia in humans, how breathing pattern modulates heart rate. Am J Physiol 241: H620-629, 1981.
14. Wheeler T and Watkins PJ: Cardiac denervation in diabetes. Br Med J 4: 584-586, 1973.
15. Ewing DJ, Campbell IW and Murray A et al: Immediate heart-rate response to standing, simple test for autonomic neuropathy in diabetes. Br Med J 1: 145-147, 1978.
16. Eckberg DL: Parasympathetic cardiovascular control in human disease: a critical review of methods and results. Am J Physiol 239: H581-H593, 1980.
17. Ekholm EMK, Vesalainen RK and Tahvanainen KUO et al: Valsalva manoeuvre can be used to study baroreflex sensitivity in pregnancy. Eur J Obstet Gynecol Reprod Biol 76: 53-156, 1998.
18. Marin Neto JA, Gallo L Jr and Manco JC et al: Mechanisms of tachycardia on standing, studies in normal individuals and in chronic Chagas' heart patients. Cardiovasc Res 14: 541-550, 1980.
19. Saul JP, Berger RD and Albrecht P et al: Transfer function of the circulation: unique insight into cardiovascular regulation. Am J Physiol 261: H1231-H1245, 1991.
20. Taylor JA and Eckberg DL: Fundamental relations between short-term RR interval and arterial blood pressure oscillations in humans. Circulation 93: 1527-1532, 1996.
21. Hedman AE, Hartikainen JEK and Tahvanainen KUO et al: Power spectral analysis of heart rate and blood pressure variability in anaesthesized dogs. Acta Physiol Scand 146: 155-164, 1992.
22. Pagani M, Montano N and Porta A et al: Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 95; 1441-1448, 1997.
23. Taylor JA, Williams TDA Seals DR et al: Low-frequency arterial pressure fluctuations do not reflect sympathetic outflow: gender and age differences. Am J Physiol 274: H1194-1201, 1998.
24. Ekholm E, Rantanen V and Antila K et al: Paclitaxel changes sympathetic control of blood pressure. Eur J Cancer 33: 1419-1424, 1997.
25. Smith JJ and Ebert TJ: General response to orthostatic stress. In: Circulatory response to upright posture (Smith JJ, ed.), Boca Raton, CRC Press, 1990, pp 1-46.